Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4111_Библиотеки_им_академика_М_И_Перельмана
.pdf
121
101. Тромбоэмболия малого круга кровообращения: Диагностика,
лечение, эндоваскулярная хирургия, профилактика / М.Д. Ханевич,
В.И. Хрупкин, В.Ф. Зубрицкий и др. М., 2003 – 232с.
102. Blumenberg RM, Barton E, Gelfand ML, Skudder P, Brennan J. Occult
deep venous thrombosis complicating superficial thrombophlebitis. J Vasc
Surg, 1998; 27: 338-343
103. Бокарев И.Н., Попова Л.В. Венозный тромбоэмболизм и
тромбоэмболия легочной артерии. - М, 2005; 208 с.
104. Бокарев И.Н., Попова Л.В., Козлова Т.В. Тромбозы и
противотромботическая терапия в клинической практике. – М, 2009;
512 с.
105. Alain Leizorovicz, Alexander T. Cohen, Alexander G.G. Turpie, Carl-
Gustav Olsson, Paul T. Vaitkus, Samuel Z. Goldhaber, for the PREVENT
Medical Thromboprophylaxis Study Group. Randomized, Placebo-
Controlled Trial of Dalteparin for the Prevention of Venous
Thromboembolism in Acutely Ill Medical Patients. Circulation. 2004; 110:
874-879
106. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon
C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N. A
comparison of enoxaparin with placebo for the prevention of venous
thromboembolism in acutely ill medical patients. Prophylaxis in Medical
Patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793–800.
107. Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH,
Tomkowski W, Turpie AG, Egberts JF, Lensing AW, ARTEMIS
Investigators Efficacy and safety of fondaparinux for the prevention of
venous thromboembolism in older acute medical patients: randomised
placebo controlled trial. BMJ. 2006;332:325–329
108. Kleber FX, Witt C, Vogel G, Koppenhagen K, Schomaker U, Flosbach
CW; THE-PRINCE Study Group. Randomized comparison of enoxaparin
with unfractionated heparin for the prevention of venous
https://t.me/med1917
122
thromboembolism in medical patients with heart failure or severe
respiratory disease. Am Heart J. 2003;145:614-621
109. The International Stroke Trial (IST): a randomised trial of aspirin,
subcutaneous heparin, both, or neither among 19435 patients with acute
ischaemic stroke. International Stroke Trial Collaborative Group. Lancet.
1997; 349:1569-1581
110. Хрипун А.И., Шурыгин С.Н., Прямиков А.Д., Миронков А.Б.,
Асратян С.А., Петренко Н.В., Абашин М.В., Латонов В.В.
Безопасность и эффективность различных схем
гепаринопрофилактики венозных тромбозов у пациентов с
внутричерепными кровоизлияниями. Ангиология и сосудистая
хирургия, 2012, №1, С20-25
111. Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the
identification of hospitalized medical patients at risk for venous
thromboembolism: The Padua Prediction Score. J Thromb Haemost. 2010;
8:2450-2457.
112. Quarrie R., Stawicki S.P. Portal vein thrombosis: What surgeons need
to know. OPUS 12 Scientist. 2008, Vol. 2, No. 3, 30-33.
113. Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Seminars
in Liver Disease. 2002;22:43-58.
114. Manzanet G, Sanjuan F, Orbis P, Lopez R, Moya A, Juan M, et al.
Liver transplantation in patients with portal vein thrombosis. Liver
Transpl. 2001;7:125-131.
115. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M,
Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of
portal vein thrombosis in patients with liver cirrhosis. J Hepatol.
2004;40:736-741.
116. Said A, Reichelderfer M, Taylor A. Portal vein obstruction. (on-line)
http://www.emedicine.com/med/topic1891.htm
https://t.me/med1917
123
117. Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH.
Portal vein thrombosis: prevalence, patient characteristics and lifetime
risk: a population study based on 23,796 consecutive autopsies. World J
Gastroenterol 2006;12:2115-2119.
118. Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein
thrombosis: risk factors, clinical presentation and treatment. BMC
Gastroenterology 2007;7:34.
119. Condat B, Pessione F, Denninger MH, Hillaire S, Valla D. Recent
portal or mesenteric venous thrombosis: increased recognition and
frequent recanalization on anticoagulant therapy. Hepatology
2000;32:466–470.
120. Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin
M, Hadengue A, Erlinger S, Valla D. Current outcome of portal vein
thrombosis in adults: risk and benefit of anticoagulant therapy.
Gastroenterology 2001;120:490-497.
121. Orlando G, De Luca L, Toti L, Zazza S, Angelico M, Casciani CU, et
al. Liver transplantation in the presence of portal vein thrombosis: report
from a single center. Transplantation Proceedings 2004;8:199-202.
122. Brett BT, Hayes PC, Jalan R, Primary prophylaxis of variceal bleeding
in cirrhosis. Eur J Gastroenterol Hepatol 2001;13:349–358.
123. Chandra R, Kapoor D, Tharakan A, Chaudhary A, Sarin SK. Portal
biliopathy. J Gastroenterol Hepatol 2001;16:1086-1092.
124. DiStefano DR, de Baere T, Denys A, Hakime A, Gorin G, Gillet M,
Saric J, Trillaud H, Petit P, Bartoli J-M, Elias D, Delpero J-R. Preoperative
percutaneous portal vein embolization: evaluation of adverse events in 188
patients. Radiology 2005;234:625-630.
125. Kocher G, Himmelmann A. Portal vein thrombosis (PVT): a study of
20 non-cirrhotic cases. Swiss Med Wkly 2005;135:372-376.
https://t.me/med1917
124
126. Özkan U, Oğuzkurt L, Tercan F, Tokmak N. Percutaneous transhepatic
thrombolysis in the treatment of acute portal venous thrombosis. Diagn
Intervent Radiol 2006;12:105-107.
127. Poplausky MR, Kaufman JA, Geller SC, Waltman AC. Mesenteric
venous thrombosis treated with urokinase via the superior mesenteric
artery. Gastroenterology 1996;110:1633–1635.
128. Reichen J. Portal vein thrombosis. Available online at:
http://www.ikp.unibe.ch/lab2/PVT.html. Last accessed on June 10, 2008.
129. Ricci P, Cantisani V, Biancari F. Contrast-enhanced color Doppler US
in malignant portal vein thrombosis. Acta Radiol 2000;41:470-473.
130. Rivitz SM, Geller SC, Hahn C, Waltman AC. Treatment of acute
mesenteric venous thrombosis with transjugular intramesenteric urokinase
infusion. J Vasc Interv Radiol 1995;6:219–223.
131. Rossi C, Zambruni A, Ansaloni F, Casadei A, Morelli C, Bernardi M,
Trevisani F. Combined mechanical and pharmacologic thrombolysis for
portal vein thrombosis in liver-graft recipients and in candidates for liver
transplantation. Transplantation 2004;78:938-940.
132. Ryu R, Lin TC, Kumpe D, et al. Percutaneous mesenteric venous
thrombectomy and thrombolysis: successful treatment followed by liver
transplantation. Liver Transpl Surg 1998;4:222–225.
133. Stein M, Link DP. Symptomatic spleno-mesenteric-portal venous
thrombosis: recanalization and reconstruction with endovascular stents. J
Vasc Interv Radiol 1999;10:363-371.
134. van’t Riet M, Burger JWA, van Muiswinkel JM, Kazemier G,
Schipperus MR, Bonjer HJ. Diagnosis and treatment of portal vein
thrombosis following splenectomy. Br J Surg 2000;87:1229-1233.
135. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X, Sainz
S, Boadas J, Cusso X, Guarner C, Balanzo J. Endoscopic ligation
compared with combined treatment with nadolol and isosorbide
https://t.me/med1917
125
mononitrate to prevent recurrent variceal bleeding. N Engl J Med
2001;345:647–655.
136. Хирургия печени и желчных путей / Под ред. проф. М.А.
Нартайлакова. – Уфа, 2005. – 2006 с.
137. Chung RT, Iafrate AJ, Amrein PC, et al. Case records of the
Massachusetts General Hospital. Case 15-2006. A 46-year-old woman
with sudden onset of abdominal distention. N Engl J Med 2006; 354:
2166-75.
138. Wang ZG, Zhang FJ, Yi MQ, Qiang LX. Evolution of management for
Budd-Chiari syndrome: a team’s view from 2564 patients. ANZ J Surg
2005; 75: 55-63.
139. Janssen HL, Garcia-Pagan JC, Elias E, et al. Budd-Chiari syndrome: a
review by an expert panel. J Hepatol 2003; 38: 364- 71.
140. Langlet P, Valla D. Is surgical portosystemic shunt the treatment of
choice in Budd-Chiari syndrome? Acta Gastroenterol Belg 2002; 65: 155-
60.
141. Navarro F, Le Moine MC, Fabre JM, et al. Specific vascular
complications of orthotopic liver transplantation with preservation of the
retrohepatic vena cava: review of 1361 cases. Transplantation 1999; 68:
646-50.
142. Wang SL, Sze DY, Busque S, et al. Treatment of hepatic venous
outflow obstruction after piggyback liver transplantation. Radiology 2005;
236: 352-9.
143. Menon KV, ShahV, Kamath PS. The Budd-Chiari syndrome. N Engl J
Med 2004; 350: 578-85.
144. Morrin MM, Pedrosa I, Rofsky NM. Magnetic resonance imaging for
disorders of liver vasculature. Top Magn Reson Imaging 2002; 13: 177-90.
145. Terasaki M, Kitai T, Morimoto T, et al. Hemodynamics and hepatic
energy metabolism in canine model of acute hepatic venous occlusion with
mesocaval shunt. Eur Surg Res 1994; 26: 19-27.
https://t.me/med1917
126
146. Denninger MH, Chaït Y, Casadevall N, et al. Cause of portal or hepatic
venous thrombosis in adults: the role of multiple concurrent factors.
Hepatology 2000; 31: 587-91.
147. Valla DC. Primary Budd-Chiari syndrome. J Hepatol 2009; 50: 195-
203.
148. Hussein K, Bock O, Kreipe H. Histological and molecular classification
of chronic myeloproliferative disorders in the Age of JAK2: persistence of
old questions despite new answers. Pathobiology 2007; 74: 72-80.
149. DeLeve LD, Valla DC, Garcia-Tsao G, American Association for the
Study Liver Diseases. Vascular Disorders of the Liver. Hepatology 2009;
49: 1729-64.
150. Mohanty D, Shetty S, Ghosh K, et al. Hereditary thrombophilia as a
cause of Budd-Chiari syndrome: a study from Western India. Hepatology
2001; 34: 666-70.
151. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J
Med 2004; 350: 578-85.
152. Wolf M, Boyer-Neumann C, Leroy-Matheron C, et al. Functional assay
of protein S in 70 patients with congenital and acquired disorders. Blood
Coagul Fibrinolysis 1991; 2: 705-12.
153. Kyriakidis AV, Vezyrgiannis I, Pyrgioti M. Budd-Chiari syndrome.
Ann Gastroenterol 2008; 21: 223-28.
154. Valla D, Le MG, Poynard T, et al. Risk of hepatic vein thrombosis in
relation to recent use of oral contraceptives. A case-control study.
Gastroenterology 1986; 90: 807-11.
155. Bismuth E, Hadengue A, Hammel P, Benhamou JP. Hepatic vein
thrombosis in Behcet’s disease. Hepatology 1990; 11: 969-74.
156. Robotti GC, Meister F, Schroeder R. Budd-Chiari syndrome bei
Leberechinockokkose. R ofo Fortschr Geb R ontgenstr- Nuklearmed 1985;
142: 511-3.
https://t.me/med1917
127
157. Schraut WH, Chilcote RR. Metastatic Wilms’ tumor causing acute
hepatic-vein occlusion (Budd-Chiari syndrome). Gastroenterology 1985;
88: 576-9.
158. Bayraktar Y, Egesel T, Saģlam F, et al. Does hepatic vein outflow
obstruction contribute to the pathogenesis of hepatocellular carcinoma? J
Clinical Gastroenterology 1998; 27: 67-71.
159. Mitchell MC, Boitnott JK, Kaufman S, et al. Budd-Chiari syndrome:
etiology, diagnosis and management. Medicine (Baltimore) 1982; 61: 199-
218.
160. Hemming AW, Langer B, Greig P, et al. Treatment of Budd-Chiari
syndrome with portosystemic shunt or liver transplantation. Am J Surg
1996; 171: 176-80.
161. Hadengue A, Poliquin M, Vilgrain V, et al. The changing scene of
hepatic vein thrombosis: recognition of asymptomatic cases.
Gastroenterology 1994; 106: 1042-7.
162. Bolondi L, Gaiani S, Li Bassi S, et al. Diagnosis of Budd-Chiari
syndrome by pulsed Doppler ultrasound. Gastroenterology 1991; 100:
1324-31.
163. Kane R, Eustace S. Diagnosis of Budd-Chiari syndrome: comparison
between sonography and MR angiography. Radiology 1995; 195:117-121.
164. Millener P, Grant EG, Rose S, et al. Color Doppler imaging findings in
patients with Budd-Chiari syndrome: correlation with venographic
findings. AJR Am J Roentgenol 1993; 161: 307-12.
165. Gupta S, Barter S, Phillips GW, et al. Comparison of ultrasonography,
computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari
syndrome. Gut 1987; 28: 242-7.
166. Noone TC, Semelka RC, Siegelman ES, et al. Budd-Chiari syndrome:
spectrum of appearances of acute, sub acute, and chronic disease with
magnetic resonance imaging. J Magn Reson Imaging 2000; 11: 44-50.
https://t.me/med1917
128
167. Kreel L, Freston J, Clain D. Vascular radiology in the Budd- Chiari
syndrome. Br J Radiol 1967; 40: 755-9.
168. Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction
(Budd-Chiari syndrome). Experience with 177 patients and a review of the
literature. Medicine (Baltimore) 1994; 73: 21-36.
169. Mancuso A. Budd-Chiari syndrome management: Lights and shadows.
World J Hepatol 2011; 3: 262-4.
170. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal
invasiveness as a therapeutic strategy for Budd-Chiari syndrome.
Hepatology 2006; 44: 1308-16.
171. Rautou PE, Douarin L, Denninger MH, et al. Bleeding in patients with
Budd-Chiari syndrome. J Hepatol 2011; 54: 56-63.
172. Eapen CE, Velissaris D, Heydtmann M, et al. Favourable medium term
outcome following hepatic vein recanalisation and/or transjugular
intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006; 55:
878-84.
173. Plessier A. [Budd Chiari syndrome]. Gastroenterol Clin Biol 2006; 30:
1162-9.
174. Plessier A, Rautou PE, Valla DC. Management of hepatic vascular
diseases. J Hepatol 2012 ; 56: S25-S38.
175. Darwish Murad D, Valla DC, de Groen PC, et al. Determinants of
survival and the effect of porto systemic shunting in patients with Budd-
Chiari syndrome. Hepatology 2004; 39: 500-8.
176. Fisher NC, McCafferty I, Dolapci M, et al. Managing Budd- Chiari
syndrome: a retrospective review of percutaneous hepatic vein angioplasty
and surgical shunting. Gut 1999; 44: 568-74.
177. Mentha G, Giostra E, Majno PE, et al. Liver transplantation for Budd-
Chiari syndrome: a European study on 248 patients from 51 centers. J
Hepatol 2006; 44: 520-8.
https://t.me/med1917
129
178. Segev DL, Nguyen GC, Locke JE, et al. Twenty years of liver
transplantation for Budd-Chiari syndrome: a national registry analysis.
Liver Transpl 2007; 13: 1285-94.
179. Kugelmas M. Budd-Chiari syndrome. Treatment options and the value
of liver transplantation. Hepatogastroenterology 1998; 45: 1381-6.
180. Garcia-Pagán JC, Heydtmann M, Raffa S, et al. TIPS for Budd- Chiari
syndrome: long-term results and prognostics factors in 124 patients.
Gastroenterology 2008; 135: 808-15.
181. Zeitoun G, Escolando S, Hadengue A, Azar N, El Younsi M, Maller A,
et al. Outcome of Budd-Chiari symndrome: a multivariative analysis of
factors related to survival including portosystemic shunting. Hepatology
2009; 30: 84-89.
182. Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma
EB, et al. Determinations of survival and the effect of portosystemic
shunting in patients with Budd-Chiari syndrome. Hepatology 2004; 39:
500-508.
183. Sharma S, Texeira A, Texeira P, Elias E, Widle J, Olliff SP.
Pharmacological thrombolysis in Budd-Chiari syndrome: a single centre
experience and review of the literature. J Hepatol 2004: 40: 172-180.
184. Шиповский В.Н. Техника операции ТИПС. Практическое
руководство. – М., 2010 – 88с.
185. Hulek P., Krajina A. Current practice of TIPS. Progresstick Hradec
Kralove (Chech Republik) 2001.
186. Wieloch M., Själander A., Frykman V., Rosenqvist M., Eriksson N.,
and Svensson P.J. Anticoagulation control in Sweden: reports of time in
therapeutic range, major bleeding, and thrombo-embolic complications
from the national quality registry AuriculA. Eur Heart J, 2011; 32 (18):
2282-89.
https://t.me/med1917
130
187. Российские клинические рекомендации по диагностике, лечению и
профилактике венозных тромбоэмболических осложнений.
Флебология, 2010, № 1.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана